Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in (A20).

MLA

Duncan, Christopher J. A., et al. “Early-Onset Autoimmune Disease Due to a Heterozygous Loss-of-Function Mutation in (A20).” Annals of the Rheumatic Diseases, vol. 77, no. 5, May 2018, pp. 783–86. EBSCOhost, https://doi.org/10.1136/annrheumdis-2016-210944.

APA

Duncan, C. J. A., Dinnigan, E., Theobald, R., Grainger, A., Skelton, A. J., Hussain, R., Willet, J. D. P., Swan, D. J., Coxhead, J., Thomas, M. F., Thomas, J., Zamvar, V., Slatter, M. A., Cant, A. J., Engelhardt, K. R., & Hambleton, S. (2018). Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in (A20). Annals of the Rheumatic Diseases, 77(5), 783–786. https://doi.org/10.1136/annrheumdis-2016-210944

Chicago

Duncan, Christopher J. A., Emma Dinnigan, Rachel Theobald, Angela Grainger, Andrew J. Skelton, Rafiqul Hussain, Joseph D. P. Willet, et al. 2018. “Early-Onset Autoimmune Disease Due to a Heterozygous Loss-of-Function Mutation in (A20).” Annals of the Rheumatic Diseases 77 (5): 783–86. doi:10.1136/annrheumdis-2016-210944.